Andere Sprachen ImmunityBio, Inc.

Aktien

A2QQ2E

US45256X1037

IBRX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 29.04.2024			Nachbörslich 22:47:43
8,99 ^USD	+22,31 %		8,975	-0,17 %

18:06	IMMUNITYBIO, INC. : Piper Sandler bekräftigt seine neutrale Bewertung	ZM
12:52	Social Buzz: Wallstreetbets-Aktien am Montag vorbörslich meist höher; Tesla, ImmunityBio im Aufwind	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Tesla, ImmunityBio to Advance	12:52
ImmunityBio : Investor Live Audio Webcast – ANKTIVA Post Approval	27.04.
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer	26.04.
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer	25.04.
ImmunityBio, Inc. Announces Positive Overall Survival Results of Anktiva Combined with Checkpoint Inhibitors in Non-Small Cell Lung Cancer	25.04.
ImmunityBio Announces FDA Approval of ANKTIVA, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer	23.04.
ImmunityBio Gaining in Tuesday Pre-Market after FDA Approval for Anktiva-Bacterium Combination for Bladder Cancer	23.04.
Upcoming Big Tech Earnings Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	23.04.
Top Premarket Gainers	23.04.
ImmunityBio Shares Soar Premarket on FDA Nod for Anktiva	23.04.
IN DIRETTA DAI MERCATI: Netweek, Ence Energia, Enel, OVS, Sogefi, Telecom Italia, ASML, Novartis, Airbus, Apple, Nvidia, Boeing...	23.04.
C'est parti pour les publications de résultats à la chaîne	23.04.
En Direct des Marchés : Renault, SAP, Sanofi, TotalEnergies, Novartis, Legrand, Tapestry, OVH...	23.04.
EN DIRECTO DESDE LOS MERCADOS: Enagas, Ence Energia, Acerinox, Naturgy, Endesa, Telefónica, Novartis, Apple, Nvidia, Boeing...	23.04.
Bolsa de Madrid: Publicación consecutiva de resultados	23.04.
US FDA approves ImmunityBio's bladder cancer therapy	23.04.
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer	23.04.
ImmunityBio, Inc. Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer	23.04.
U.S. FDA approves ImmunityBio's bladder cancer therapy	23.04.
ImmunityBio Files Mixed Shelf	17.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ImmunityBio, Inc.

Aktien

A2QQ2E

US45256X1037

IBRX

Andere Sprachen

Filter